The Patient Protection and Affordable Care Act, known as the ACA, calls for quality initiatives such as comparative effectiveness research to increase effective, appropriate, and high-value care. This paper, by NMDP/Be The Match Payor Policy and other staff, reviews the main provisions of the ACA with specific attention to their impact on the field of hematopoietic cell transplantation. The authors discuss the new forms of payment reform that providers need to be aware of, particularly in the Medicare program. Other topics include new insurance coverage protections and increased access to care for patients, as well as payment reform, health insurance markets, and expanded Medicaid coverage.
Farnia S, et al. Curr Hematol Malig RepImpact of the Affordable Care Act on HCT
Jan 2014